Skip to main content
All
Stories
Press Releases
Documents
Events
Updates
Other
Press shift tab to select search category
Loading...
Press Releases
Investors
Partnering
Careers
< Back
Careers
Careers
Working at Ipsen
All
Stories
Press Releases
Documents
Events
Updates
Other
Press shift tab to select search category
X
Loading...
EN
English
EN
Français
FR
Canada
<
Global
EN
FR
Annual Report
EN
FR
Americas
Asia Pacific
Europe
Middle East & Africa
Brazil
Canada
United States
Mexico
Australia
China
Singapore
South Korea
Japan
Belgium
Ukraine
UK
Germany
France
Nordics
Greece
Italy
Netherlands
Spain
Poland
Russia
Czech Republic
Romania
Hungary
Slovakia
Switzerland
Austria
UAE & Gulf
Saudi Arabia
Home
Company
< Back
Company
Who We Are
Leadership
Our History
Science
< Back
Science
Areas of Focus
Products
Clinical Trials
R&D
Grant Requests
Investigator Sponsored Studies
Sustainability
< Back
Sustainability
Sustainability
Environment
People
Governance
Charitable Contributions
Patients
Post navigation
Next
Cabometyx® (cabozantinib)
Cabometyx® (cabozantinib)
-
20 August 2024
-
0 mins read
Post navigation
Next
Related Documents
Click here to view Product Monograph
(773 KB)
X
You are now leaving the Ipsen Canada website. To continue, please click Continue.
